Ryu Yanagisawa1,2,3, Yozo Nakazawa2, Kazuyuki Matsuda4, Takahiro Yasumi5, Hirokazu Kanegane6, Shouichi Ohga7, Akira Morimoto8, Akiko Saito3, Keizo Horibe3, Eiichi Ishii3,9 (1.Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan, 2.Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan, 3.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 4.Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan, 5.Department of Pediatrics, Kyoto University, Kyoto, Japan, 6.Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan, 7.Department of Pediatrics, Kyushu University, Fukuoka, Japan, 8.Department of Pediatrics, Jichi Medical University of Medicine, Tochigi, Japan, 9.Department of Pediatrics, Ehime University, Toon, Japan)
Session information
Oral Session
Oral Session 1-8C Malignant Lymphoma: Prognostic factors
Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.8 (Osaka International Convention Center, 10F 1002)
Chair: Takashi Watanabe (Department of Immuno-Gene Therapy Mie University Graduate School of Medicine, Japan)
Kazuhiro Toyama, Ayato Tsukamoto, Sho Yamazaki, Fumihiko Nakamura, Mineo Kurokawa (Department of Hematology and Oncology, The University of Tokyo)
[OS1-8C-3] Indoleamine 2, 3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies
Takeshi Hara1,2, Yuhei Shibata2, Ryoko Mabuchi2, Takuro Matsumoto2, Nobuhiko Nakamura2, Hiroshi Nakamura2, Soranobu Ninomiya2, Junichi Kitagawa2, Nobuhiro Kanemura2, Kenji Fukuno2, Hisashi Tsurumi1,2 (1.Dept. Hematol., Matsunami General Hosp., Gifu, Japan, 2.Dept. Hematol., Gifu Univ., Gifu, Japan)
Shin Lee1,2, Eiju Negoro1, Hikaru Tsukasaki2, Keiichi Kinoshita2, Shin Imamura2, Kenichi Kamiya2, Takanori Ueda1, Takahiro Yamauchi1 (1.Department of Hematology and Oncology, University of Fukui, Fukui, Japan, 2.Department of Hematology, Fukui Red Cross Hospital, Fukui, Japan)
Yotaro Motomura, Tomoyuki Arimatsu, Saeko Sonokawa, Sayaka Suzuki, Keigo Okada, Takashi Kumagai (Department of Hematology, Ome Municipal General Hospital, Tokyo, Japan)
Masako Nishikawa1, Makoto Kurano1, Takahiro Nitta2, Hirotaka Kanoh2, Jin-Ichi Inokuchi2, Yutaka Yatomi1 (1.Department of Clinical Laboratory Medicine, University of Tokyo, Tokyo, Japan, 2.Division of Glycopathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan)